MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    Impact of globus pallidus interna deep brain stimulation on REM sleep behavior disorder in Parkinson’s disease

    A. Mahes, A. Wiltshire, S. Wang, J. Zuzuarregui (San Francisco, USA)

    Objective: The aim of this study was to determine if there is an improvement in rapid eye movement (REM) sleep behavior disorder (RBD) for patients…
  • 2023 International Congress

    Pain as a Risk Factor for Developing Depression among Patients with Parkinson’s Disease: A Systematic Review of 1426 patients

    S. Mohammed, A. Eldeen (Sohag, Egypt)

    Objective: This systematic review aims mainly to investigate pain as an independent risk factor for developing depressive symptoms among patients with PD. Background: Parkinson's disease…
  • 2023 International Congress

    Pseudogout Mimicking Stiffness in Parkinson’s Disease: A Case Report

    S. Kazanci, M. Afshari, J. Fleisher (Chicago, USA)

    Objective: N/A Background: Levodopa-responsive muscular rigidity is one of the hallmarks of Parkinson’s disease (PD). Many rheumatological conditions can present with stiffness1-4. For example, polymyalgia…
  • 2023 International Congress

    Deep brain stimulation for movement disorders: Assessing disparities in access to care

    Z. Rifi, M. Harary, L. Remore, K. Fu, A. Bari (Los Angeles, USA)

    Objective: To investigate the impact of non-disease related factors (sex, race, age, language, or socioeconomic status) on the likelihood of movement disorders patients receiving Deep…
  • 2023 International Congress

    A comparative study of non-motor symptoms in Huntington’s disease and Parkinson’s disease

    WZ. Hu, JH. Yin, LX. Cao, Y. Huang (Beijing, China)

    Objective: To assess and compare the non-motor symptoms (NMS) profile in Parkinson's disease (PD) and Huntington's disease (HD) patients using Parkinson's Disease Non-Motor Symptom Rating…
  • 2023 International Congress

    Assessing the swallow tail sign in clinical practice

    MA. Ruiz Yanzi, E. Natera-Villalba, JA. Pineda-Pardo, M. Matarazzo (Madrid, Spain)

    Objective: To evaluate the swallow tail sign accuracy to distinguish between essential tremor (ET) and Parkinson’s disease (PD) in clinical practice.  Background: The swallow tail…
  • 2023 International Congress

    How to dose extended-release carbidopa-levodopa capsules (IPX203) in Parkinson’s disease patients: Experience from the Phase 3 clinical trial

    R. Hauser, G. Banisadr, S. Fisher, H. Visser, R. D'Souza (Tampa, USA)

    Objective: To provide guidance on dosing of IPX203 based on clinical trial experience. Background: IPX203 is an extended-release, oral carbidopa-levodopa (CD-LD) formulation designed to rapidly…
  • 2023 International Congress

    A validation study of the Mini-BESTest in a Spanish population with Parkinson’s disease.

    A. García Bustillo, F. Valiñas Sieiro, M. Allende Río, A. Olivares Gil, JL. Garrido Labrador, JM. Ramírez Sanz, M. Jahouh, A. Arnaiz González, JF. Díez Pastor, N. Mariscal, S. Calvo Simal, J. Rivadeneyra-Posadas, L. Simón Vicente, J. González Santos, JJ. González Bernal, JM. Gabriel Galán, E. Cubo (Burgos, Spain)

    Objective: Because the Mini Balance Evaluation Systems Test (Mini-BESTest) is widely used, our aim was to validate the Spanish version in PD. Background: Parkinson's disease…
  • 2023 International Congress

    The Effects of Motor Imagery Therapy in the rehabilitation of patients with Parkinson’s Disease: A Systematic Review

    A. Ibrahim Abdelhamed, M. Abdeen, H. Elkhodary, A. Samir, A. El-Shazly, M. Zaghloul, A. Abdelmalek, E. Elbathesh, R. Salem, A. Mohamed, A. Ashour, M. Fahmy, H. Samy, M. Shafiek Saleh (Elfashn, Egypt)

    Objective: This systematic review summarizes all published outcomes of Parkinson’s patients treated with Motor Imagery Therapy. Background: Parkinson's disease (PD) is one of the most…
  • 2023 International Congress

    Update on the ADOPTION Study: Randomised, Open-Label Exploratory Trial of Opicapone in Parkinson’s Disease

    J. Ferreira, W. Poewe, O. Rascol, F. Stocchi, A. Antonini, R. Costa, D. Magalhães, J. Rocha, P. Soares-da-Silva (Lisbon, Portugal)

    Objective: This exploratory trial aims to compare treatment outcomes of adding one daily dose of opicapone (OPC) 50 mg versus an additional dose of levodopa…
  • « Previous Page
  • 1
  • …
  • 331
  • 332
  • 333
  • 334
  • 335
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley